Navigation Links
BioMarin Receives Notice of Allowance for Once Daily Dosing Patent for Kuvan
Date:3/30/2009

NOVATO, Calif., March 30 /PRNewswire-FirstCall/ -- BioMarin Pharmaceutical Inc. (Nasdaq: BMRN) announced today that it has received a notice from the United States Patent Office reporting allowance of claims covering once daily dosing methods for Kuvan(R) (sapropterin dihydrochloride) in the treatment of phenylketonuria (PKU). The company expects that the patent will be officially issued later this year, and if issued, the patent's initial 20-year term would expire in 2024. The company has a number of other pending patent applications covering various aspects of Kuvan compositions and dosing.

"We believe the issuance of this patent will be significant in strengthening our proprietary position on Kuvan," said Jean-Jacques Bienaime, Chief Executive Officer of BioMarin. "This patent would prevent potential competitors from using or copying Kuvan's approved dosing regimen. Based on the claims allowed by the USPTO, we believe that the once daily dosing regimen will prevent therapeutically equivalent generic competition to Kuvan while the patent is in force."

About Kuvan

Kuvan (sapropterin dihydrochloride) Tablets are indicated in the United States to reduce blood phenylalanine (Phe) levels in patients with hyperphenylalaninemia (HPA) due to tetrahydrobiopterin- (BH4-) responsive phenylketonuria (PKU). Kuvan is to be used in conjunction with a Phe-restricted diet.

The active ingredient in Kuvan, sapropterin dihydrochloride, is the synthetic form of 6R-BH4 (tetrahydrobiopterin), a naturally occurring enzyme cofactor that works in conjunction with phenylalanine hydroxylase (PAH) to metabolize Phe.

Kuvan has received orphan drug designation from both the U.S. Food and Drug Administration (FDA) and the European Medicines Agency (EMEA). Kuvan has received seven years of orphan e
'/>"/>

SOURCE BioMarin Pharmaceutical Inc.
Copyright©2009 PR Newswire.
All rights reserved

1

GOOD

Page: 1 2 3 4

Related biology technology :

1. BioMarin to Present at the 4th Annual Citi Biotech Day
2. BioMarins Clinical Trial Application for GALNS for Morquio A Syndrome Accepted by the MHRA
3. BioMarin Announces Fourth Quarter and Full Year 2008 Financial Results
4. BioMarin to Host Fourth Quarter and Full Year 2008 Financial Results Conference Call and Webcast on Wednesday, February 18 at 5:00 p.m. ET (23:00 CET)
5. BioMarin to Present at the Piper Jaffray Healthcare Conference
6. BioMarin Announces the Planned Retirement of Dr. Emil Kakkis, Chief Medical Officer
7. BioMarin to Present at the Credit Suisse Healthcare Conference
8. BioMarin Announces Third Quarter 2008 Financial Results
9. BioMarin Corrects Information Included in Bloomberg Article
10. BioMarin to Present at the Merrill Lynch Global Pharmaceutical Conference
11. BioMarin to Present at the Morgan Stanley Global Healthcare Conference

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/24/2009)...ewswire-FirstCall/ -- NeurogesX, Inc. (Nasdaq: NG...oping and commercializing novel pain management th...sident and Chief Executive Officer, is scheduled t...Care Conference, to be held December 1-2, 2009 at ...,, Mr. DiTonno and Stephen Ghiglieri, Chief Fin...
(Date:11/24/2009)...oved the Promega PowerPlex 16 HS System for use by...ecords for the National DNA Index System. , ...FBI recently approved the Promega PowerPlex® ...g in, or generating DNA records for, the National ...ore than seven million profiles and has assisted i...
(Date:11/24/2009)...e-FirstCall/ -- Shire plc (LSE: SHP,NASDAQ: SHPG...y, today,announced that it has submitted a MAA to ...fa, the company,s enzyme replacement therapy in de...ase. This is the third marketing,application for v...evious,submissions in the United States and Canada...
(Date:11/24/2009)...RNewswire/ -- Health Robotics today announced,that... group of selected,investors. This recently formed... Health Robotics Canada, Inc. and will market, ins...e Future concept, which includes the,revolutionary...and OMM(TM).,Health Robotics Canada Inc. will also...
Breaking Biology Technology:NeurogesX to Present at Piper Jaffray Health Care Conference 2NeurogesX to Present at Piper Jaffray Health Care Conference 3NDIS Approval of Promega PowerPlex Kit Clears Path for More DNA Profiles to be Added to U.S. Database 2Shire Submits European Marketing Authorization Application (MAA) for velaglucerase alfa for the Treatment of Type 1 Gaucher Disease 2Shire Submits European Marketing Authorization Application (MAA) for velaglucerase alfa for the Treatment of Type 1 Gaucher Disease 3Shire Submits European Marketing Authorization Application (MAA) for velaglucerase alfa for the Treatment of Type 1 Gaucher Disease 4Health Robotics Continues its Global Expansion With December 09 ASHP's Launch of Joint Venture in Canada 2Health Robotics Continues its Global Expansion With December 09 ASHP's Launch of Joint Venture in Canada 3
...GE, Tenn., Jan. 17, 2008 Scientific studies on cl...ng the 30 projects awarded more than 145 million p...ional Laboratory through the Department of Energys...ry and Experiment (INCITE) program. , Through I...ernment research facilities receive access to comp...
..., Holder Completes First Year Inspiring Others to ...tions, VALLEY FORGE, Pa., Jan. 17 In 2007, Good ... teamed up with "Iron Andy" Holder,as part of the ...n. Andy,set out to speak about living with diabete...ted with dozens of individuals who were inspired b...
...Previous Guidance for 2007, MADISON, N.J., Jan. 1...he nation,s leading provider of diagnostic,testing... report results,for the fourth quarter and year en...ce for 2008 on February 21, 2008, instead of the p...any is rescheduling its report of fourth quarter a...
Other Biology Technology:Oak Ridge leads DOE INCITE effort in 2008 2Oak Ridge leads DOE INCITE effort in 2008 3Oak Ridge leads DOE INCITE effort in 2008 4Good Neighbor Pharmacy(R) Ironman Competitor Inspires Individuals with Diabetes to Live Without Limits 2Good Neighbor Pharmacy(R) Ironman Competitor Inspires Individuals with Diabetes to Live Without Limits 3Quest Diagnostics Sets New Date to Report Fourth Quarter and Full Year 2007 Results 2Quest Diagnostics Sets New Date to Report Fourth Quarter and Full Year 2007 Results 3
(Date:11/24/2009)...s Research Institute (LRI) today named 12 new gran...illion, recognize innovative work across a broad s...heir creativity, novelty, and potential to drive s...and cure the complex disease of systemic lupus. ,...upus researchers across the nation and include int...
(Date:11/24/2009)...ic-level action of a remarkable class of ring-shap...s with the Lawrence Berkeley National Laboratory (...stallography beamline at the Advanced Light Source... gene expression and replication, and are vital to...infectious agents, such as the human papillomaviru...
(Date:11/24/2009)...nstitutes fish food is a matter of debate. A high-...get almost 50 percent of their carbon from trees a...the terrestrial and aquatic ecosystems. , But ne... this is not likely to be true. Algae provide a mu...cording to research published this week in the Pr...
Breaking Biology News(10 mins):Lupus Research Institute announces 2009 novel research grants 2Lupus Research Institute announces 2009 novel research grants 3Atomic-level snapshot catches protein motor in action 2Atomic-level snapshot catches protein motor in action 3Atomic-level snapshot catches protein motor in action 4Fish food fight: Fish don't eat trees after all, says new study 2Fish food fight: Fish don't eat trees after all, says new study 3WuXi PharmaTech Files 2008 Annual Report on Form 20 F 50138 1WuXi PharmaTech Files 2008 Annual Report on Form 20 F 50138 2High carbon dioxide levels cause abnormally large fish ear bones 9012 1High carbon dioxide levels cause abnormally large fish ear bones 9012 2SEIU UHW Members Win Key Vote to Keep Union at Calif Hospital 50136 1SEIU UHW Members Win Key Vote to Keep Union at Calif Hospital 50136 2
...chologists have long known that memories of distur... or the unexpected death of a loved one - are more...ane recollections of everyday matters. , Probing ... the University of Wisconsin-Madison have found th...n fire up two memory-forming regions of the brain ...
...om from a West Indian tarantula has been shown to ...e that sense high temperatures and the hot, spicy ...discovered. , The findings demonstrate that some p...strategy to deter predators -- triggering pain by ...The research provides new tools to understand how ...
... gardener knows--different plant species mature at...ities in natural habitats call this phenomenon "co... because it reduces overlap in the time period whe... study posted online the week of Sept. 4 in the Pr...logists working at Stanford,s Jasper Ridge Biologi...
Other Biology News:Anticipation plays a powerful role in human memory, brain study finds 2Anticipation plays a powerful role in human memory, brain study finds 3Tarantula venom and chili peppers target same pain sensor 2Global changes alter the timing of plant growth, scientists say 2Global changes alter the timing of plant growth, scientists say 3
...oresearch: Developed for a wide range of bioanalyt...ience in Luminescence Spectroscopy • Automate...graphic gratings for reduced stray light • Ve...ed Xenon lamp reduces photo bleaching • Large...
...ys contain 60 rabbit tissue samples arrayed on Sup...ins 4 unstained slides and 1 hematoxylin and eosin...e contains 15 different tissues from 4 rabbit orga... Each tissue sample (or core) is 1.5 mm in diamete...
...lla typhimurium The genus Salmonella is a member ...posed of Gram-negative bacilli that are facultativ... major antigens; the "H" or flagellar antigen (pha... LPS moiety) and the "Vi" or capsular antigen (ref...
PerkinElmer Spectrum Beer's Law QUANT Quantitative Software, CD from PerkinElmer
Biology Products: